COMMUNIQUÉS West-GlobeNewswire

Akari Therapeutics to Provide Update on its Eye Disease Program During Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
27/03/2019
Poster to be presented on back-of-the-eye program including data from uveitis preclinical model Interim data expected from Akari’s Phase I/II clinical trial in atopic keratoconjunctivitis (AKC), a surface of the eye [...]
California Legislature Seeks to Remove Private Physicians from Decisions on Medical Vaccine Exemptions, States Association of American Physicians and Surgeons (AAPS)
27/03/2019
TUCSON, Ariz., March 27, 2019 (GLOBE NEWSWIRE) -- California has already done away with religious and philosophical exemptions from mandated childhood vaccines , reports the Association of American Physicians and [...]
Equillium Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights
27/03/2019
Initiated the EQUATE Phase 1b/2 trial in acute graft-versus-host disease in March 2019 LA JOLLA, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company leveraging deep [...]
electroCore Announces Fourth Quarter and Full Year 2018 Financial Results
27/03/2019
Fourth quarter 2018 prescription growth of more than 30% from third quarter 2018 Company to host conference call and webcast today, March 27, at 4:30pm ET BASKING RIDGE, N.J., March 27, 2019 (GLOBE NEWSWIRE) -- [...]
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
27/03/2019
– Conference Call Scheduled March 27, 2019 at 4:30 p.m. EDT – BERKELEY HEIGHTS, N.J., March 27, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") a [...]
HTG Introduces the HTG EdgeSeq Mouse mRNA Tumor Response Panel
27/03/2019
TUCSON, Ariz., March 27, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has released a new HTG [...]
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
27/03/2019
WATERTOWN, Mass., March 27, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Osmotica Pharmaceuticals plc Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress
27/03/2019
Reported fourth quarter and full year 2018 total revenue of $65.7 million and $263.7 million, respectively Completed and reported preliminary topline results from second Phase III study of arbaclofen extended-release ( [...]
Stryker announces new Vice President, Chief Legal Officer
27/03/2019
Kalamazoo, Michigan, March 27, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Rob Fletcher will be joining the company as Vice President, Chief Legal Officer effective April 22, 2019. Mike Hutchinson [...]
CrownBio et Hubrecht Organoid Technology annoncent un partenariat stratégique, comprenant une licence exclusive pour la fourniture de services de développement et de validation de médicaments précliniques à base d'organoïdes oncologiques
27/03/2019
Ce partenariat associe une technologie organoïde révolutionnaire à la plus grande collection PDX au monde pour créer une plateforme unique de recherche translationnelle dérivée du patient. SAN DIEGO, 27 mars 2019 (GLOBE [...]
Professional Hockey Players’ Association Chooses Brain Armor® as Official Brain Health Supplement
27/03/2019
Brookfield, WI, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, through their Brain Armor® subsidiary, is pleased to announce that the [...]
Resolution passed at the Annual General Meeting
27/03/2019
Orphazyme A/S Company announcement No. 10/2019 Company Registration No. 32266355 Copenhagen, March 27, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients [...]
New Psychemedics Offering Further Enhances Cocaine Detection
27/03/2019
Industry’s first commercial application of hydroxycocaines for detection SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ), the world leader in detecting drugs of [...]
Genfit: MISE À DISPOSITION DU PROSPECTUS AYANT RECU LE VISA NO. 19-118 DE L’AUTORITÉ DES MARCHÉS FINANCIERS EN DATE DU 27 MARS 2019 DANS LE CADRE DE SON INTRODUCTION EN BOURSE AUX ÉTATS-UNIS
27/03/2019
CE COMMUNIQUÉ N’EST PAS DESTINÉ A ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE NI À DES RESSORTISSANTS AMÉRICAINS (« U.S. PERSONS »), POUR LEUR BÉNÉFICE OU POUR LEUR COMPTE [...]
Announcement from Nordic Transport Group A/S regarding consolidation with NeuroSearch and notification from Nasdaq to NeuroSearch
27/03/2019
Company announcement 27 March 2019 NeuroSearch A/S ("NeuroSearch") has today received the attached announcement from Nordic Transport Group ("NTG)". Proposals will be made to the Annual General Meeting of NeuroSearch to [...]
Harvest One Executing on Brands and Distribution Strategy -- CFN Media
27/03/2019
SEATTLE, March 27, 2019 (GLOBE NEWSWIRE) -- NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Resverlogix Announces Ninth Positive Data Safety Monitoring Board Recommendation for Phase 3 Study of Apabetalone
27/03/2019
BETonMACE trial to continue as planned without modification CALGARY, Alberta, March 27, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces the independent Data and [...]
ViroGates publishes its Annual Report 2018
27/03/2019
Company announcement no. 3-2018 Birkerød, 27 March 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for emergency departments in hospitals, today published its Annual [...]
Immutep to Host Eftilagimod Alpha Clinical Development Update Global Webcast
27/03/2019
SYDNEY, Australia, March 27, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

Pages